Portfolio news 0

Accelercomm Ltd

AccelerComm and Radisys Expand Satellite 5G Capabilities to Power Global IoT and Broadband Services

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Annual results for the year ended 31 December 2025

Artios Pharma

Artios Reports Randomized Phase 2a Study of Low Dose Alnodesertib Plus Gemcitabine Achieves Primary Endpoint in Platinum-Resistant Ovarian Cancer

First Light Fusion Ltd

First Light Fusion and Locai Labs announce research collaboration to broaden the application of AI in fusion energy research

Oxford Nanopore Technologies Plc

Oxford Nanopore Technologies plc - Update on legal action against MGI Australia Pty Ltd., in the Federal Court of Australia

Genomics

Minister for Health Innovation Dr Zubir Ahmed MP and Executive Chair for the Office of Life Sciences Steve Bates OBE open Genomics’ flagship office in London’s Knowledge Quarter, as it unveils Agentic AI capabilities within Mystra drug discovery Platform

First Light Fusion Ltd

First Light Fusion validates high tritium breeding performance of FLARE concept, addressing key barrier to fusion energy scale-up

Artios Pharma

Artios Receives U.S. FDA Fast Track Designation for DNA Polymerase Theta (Polθ) Inhibitor ART6043 for Treatment of gBRCA-mutated HER2-Negative Breast Cancer

Artios Pharma

Artios Strengthens Leadership Team to Accelerate Late-Stage Development of Potential First-in-Class Oncology Pipeline

Microbiotica Ltd

Microbiotica announces impressive results in its Phase 1b trial of MB310 in Ulcerative Colitis